Trends in incidence of, and mortality from, cervical lesions in Ireland: Baseline data for future evaluation of the national cervical screening programme

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 830-835

  O'Brien, Katie M ^a   Sharp, Linda ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Cervical cancer; Incidence and mortality trends; Opportunistic screening; Organised screening

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; IRELAND; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL CANCER; INCIDENCE AND MORTALITY TRENDS; OPPORTUNISTIC SCREENING; ORGANISED SCREENING;

ADENOCARCINOMA; ADOLESCENT; ADULT; CANADA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; IRELAND; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84888308099     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.09.002     Document Type: Article

References (38)

1. Arbyn M., Castellsagué X., de Sanjosé S., Bruni L., Saraiya M., Bray F., et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 2:2675-2686.
2. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19.
3. Bosch F., Lorincz A., Munoz N., Meijer C., Shah K. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55(4):244-265.
4. Karsa L., Anttila A., Ronco G., Ponti A., Malila N., Arbyn M., et al. Cancer screening in the European union, report on the implementation of the council recommendation on cancer screening 2008, Cancer Screening in the European Union.
5. Cervix cancer screening/IARC working group on the evaluation of cancer - preventive strategies (2004: Lyon, France), IARC handbooks of cancer prevention; 10.
6. Arbyn M., Rebolj M., de Kok I.M., Becker N., O'Reilly M., Andrae B. The challenges for organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009, 45:2671-2678.
7. Arbyn M., Raifu A.O., Weiderpass E., Bray F., Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009, 45:2640-2648.
8. CervicalCheck Ireland - 2007 report [Internet]; [cited 08.20.12]. Available from: http://www.cervicalcheck.ie/_fileupload/File/NCSS%20Annual%20Report%202007-2008%20-%20Final.pdf.
9. Comber H., Gavin A. Recent trends in cervical cancer mortality in Britain and Ireland: The case for population-based cervical cancer screening. Br J Cancer 2004, 91(11):1902-1904.
10. CI5vol9-4.pdf (application/pdf object) [Internet] [cited 11.07.12]. Available from: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-4.pdf.
11. WHO Cancer mortality database (IARC) [Internet]; 2010 [cited 15.09.12]. Available from: http://www-dep.iarc.fr/WHOdb/WHOdb.htm.
12. PHIS2012, Public Health Information System, Information Unit, Department of Health, Ireland.
13. Kim H.J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 2000, 19(3):335-351.
14. Smith P. Comparison between registries: age standardised rates. Cancer incidence in five continents, vol. V 1987, IARC Scientific Publications: International Agency for Research on Cancer, Lyon, France.
15. Kelly A., Teljeur C. A new national deprivation index for health and health services research: Short report. Small Area Health Research Unit, Department of Public Health and Primary Care 2004, Trinity College, Dublin.
16. Jensen O.M. Cancer registration: principles and methods 1991, IARC Scientific Publications, Lyon, France.
17. O'Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish national cancer registry. Irish Journal of Medical Science, 2013. doi:10.1007/s11845-013-0993-z.
18. Winer R.L., Koutsky L.A. The epidemiology of human papillomavirus infections. Cancer Prevention-Cancer Causes. Cervical cancer: from etiology to prevention 2004, 2:143-187.
19. Layte R.D., McGee H.P., Quail A., Rundle K., Cousins G., Donnelly C.D., et al. The Irish study of sexual health and relationships health among young people in Ireland main report 2006, Crisis Pregnancy Agency, Department of Health and Children (DOHC).
20. Castellsagué X., Muñoz N. Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. JNCI Monographs 2003, 2003(31):20-28.
21. Wilson-Davis K. Some results of an Irish family planning survey. J Biosoc Sci 1975, 7(04):435-444.
22. Mason C. Crisis pregnancy agency report no. 5, contraceptive needs: The evidence, a literature review; 2004.
23. Condon F., Collins R., Jenkins D. Sexual and contraceptive practice in an Irish university. Ir Med J 1993, 86(6):206.
24. Wiley M.M., Merriman B. Women and health care in Ireland: knowledge, attitudes and behaviour 1996, Oaktree Press, Dublin.
25. Central Statistics Office, Vital Statistics, Cork, Ireland.
26. European Centre for Disease Prevention and Control/WHO Regional Office for Europe HIV/AIDS surveillance in Europe 2009 2010, European Centre for Disease Prevention and Control, Stockholm.
27. Bray F., Carstensen B., Møller H., Zappa M., Žakelj M.P., Lawrence G., et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005, 14(9):2191-2199.
28. Li N., Franceschi S., Howell-Jones R., Snijders P.J.F., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011, 128:927-935.
29. Sasieni P., Castanon A., Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 2009, 125(3):525-529.
30. ní Riain A., Stewart M., Phelan D., Bury G., Mulcahy F. Cervical smears: comparison of knowledge and practice of a general practice sample with a high-risk group. Int J STD AIDS 2001, 12(3):171-175.
31. Goodall V.J. A study of the prevalence of cervical smear testing within female patients of a north cork practice, and their understanding of the nature of cervical screen testing. Ir Med J 2001, 94(January (1)):23-24.
32. Raffle A., Alden B., Quinn M., Babb P., Brett M. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. Brit Med J 2003, 326(7395):901.
33. Lynge E., Clausen L.B., Guignard R., Poll P. What happens when organization of cervical cancer screening is delayed or stopped?. J Med Screen 2006, 13(1):41-46.
34. Arbyn M., Anttila A., et al. European guidelines for quality assurance in cervical cancer screening. Second edition - summary document. Ann Oncol 2010, 21:448-458.
35. Sasieni P., Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. Brit Med J 1999, 318(7193):1244-1245.
36. Faggiano F., Partanen T., Kogevinas M., Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1997, (138):65.
37. Bosch F., Muñoz N., Sanjosé S. Human papillomavirus and other risk factors for cervical cancer. Biomed Pharmacother 1997, 51(6):268-275.
38. Moser K., Patnick J., Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. Brit Med J 2009, 338.